Effects of probiotics on acquisition and spread of multiresistant enterococci

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2801-2805

  De Regt, Marieke J A ^a   Willems, Rob J L ^a   Hené, Ronald J ^a   Siersema, Peter D ^a   Verhaar, Harald J J ^a   Hopmans, Titia E M ^a   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENTEROCOCCUS FAECIUM; EVENING DOSAGE; GENE LOCUS; GENOTYPE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORNING DOSAGE; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT; DRUG EFFECTS; ENTEROCOCCUS; FEMALE; GENETICS; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PHYSIOLOGY;

AGED; AMPICILLIN RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBIOTICS; PROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE;

EID: 77953756363     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01765-09     Document Type: Article

References (24)

1. Akaike, H. 1974. A new look at the statistical model identification. IEEE Trans. Automat. Contr. 19:716-723.
2. Besselink, M. G., H. C. van Santvoort, E. Buskens, M. A. Boermeester, H. van Goor, H. M. Timmerman, V. B. Nieuwenhuijs, T. L. Bollen, B. van Ramshorst, B. J. Witteman, C. Rosman, R. J. Ploeg, M. A. Brink, A. F. Schaapherder, C. H. Dejong, P. J. Wahab, C. J. van Laarhoven, E. van der Harst, C. H. van Eijck, M. A. Cuesta, L. M. Akkermans, and H. G. Gooszen. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651-659.
3. Bonten, M. J., S. Slaughter, A. W. Ambergen, M. K. Hayden, J. van Voorhis, C. Nathan, and R. A. Weinstein. 1998. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch. Intern. Med. 158:1127-1132.
4. de Regt, M. J., L. E. van der Wagen, J. Top, H. E. Blok, T. E. Hopmans, A. W. Dekker, R. J. Hene, P. D. Siersema, R. J. Willems, and M. J. Bonten. 2008. High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital. J. Antimicrob. Chemother. 62:1401-1406.
5. Donskey, C. J., J. A. Hanrahan, R. A. Hutton, and L. B. Rice. 2000. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis. 181:1830-1833.
6. Fisher, L. D., and D. Y. Lin. 1999. Time-dependent covariates in the Cox proportional-hazards regression model. Annu. Rev. Public Health 20:145-157.
7. Grayson, M. L., G. M. Eliopoulos, C. B. Wennersten, K. L. Ruoff, P. C. De Girolami, M. J. Ferraro, and R. C. Moellering, Jr. 1991. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemother. 35:2180-2184.
8. Guarino, A., A. Lo Vecchio, and R. B. Canani. 2009. Probiotics as prevention and treatment for diarrhea. Curr. Opin. Gastroenterol. 25:18-23.
9. Harbarth, S., S. Cosgrove, and Y. Carmeli. 2002. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 46:1619-1628.
10. Hayden, M. K. 2000. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin. Infect. Dis. 31:1058-1065.
11. Hayden, M. K., M. J. Bonten, D. W. Blom, E. A. Lyle, D. A. van de Vijver, and R. A. Weinstein. 2006. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin. Infect. Dis. 42:1552-1560.
12. Hickson, M., A. L. D'Souza, N. Muthu, T. R. Rogers, S. Want, C. Rajkumar, and C. J. Bulpitt. 2007. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335:80.
13. Hidron, A. I., J. R. Edwards, J. Patel, T. C. Horan, D. M. Sievert, D. A. Pollock, and S. K. Fridkin. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
14. Koning, C. J., D. M. Jonkers, E. E. Stobberingh, L. Mulder, F. M. Rombouts, and R. W. Stockbrugger. 2008. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am. J. Gastroenterol. 103:178-189.
15. Kuipers, M. I. 2006. Selected probiotic bacteria disrupt biofilm development of vancomycin-resistant Enterococcus faecium, abstr. 20-21. Biofilms II Int. Conf., Leipzig, Germany, 23 to 24 March 2006.
16. Leavis, H. L., M. J. Bonten, and R. J. Willems. 2006. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr. Opin. Microbiol. 9:454-460.
17. Leavis, H. L., R. J. Willems, W. J. van Wamel, F. H. Schuren, M. P. Caspers, and M. J. Bonten. 2007. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog. 3:e7.
18. Manley, K. J., M. B. Fraenkel, B. C. Mayall, and D. A. Power. 2007. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med. J. Aust. 186:454-457.
19. Murray, B. E. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721.
20. Sullivan, A., C. Edlund, and C. E. Nord. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:101-114.
21. Taylor, E. W., V. Poxon, J. Alexander-Williams, and D. Jackson. 1983. Biliary excretion of piperacillin. J. Int. Med. Res. 11:28-31.
22. Therneau, T. M., and P. M. Grambsch. 2000. Modeling survival data: extending the Cox model. Springer, New York, NY.
23. Top, J., N. M. Banga, R. Hayes, R. J. Willems, M. J. Bonten, and M. K. Hayden. 2008. Comparison of multiple-locus variable-number tandem repeat analysis and pulsed-field gel electrophoresis in a setting of polyclonal endemicity of vancomycin-resistant Enterococcus faecium. Clin. Microbiol. Infect. 14:363-369.
24. Top, J., R. Willems, H. Blok, M. de Regt, K. Jalink, A. Troelstra, B. Goorhuis, and M. Bonten. 2007. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin. Microbiol. Infect. 13:316-319.